Clinical Trials
Wilmot Cancer Institute offers the largest portfolio of clinical trials for gynecologic cancers in the region. The Gynecologic Oncology Division is a member of the NRG, a cooperative group funded by the National Cancer Institute. Eligible Wilmot patients therefore have access to many of the NRG clinical trials.
Clinical trials are research studies that directly involve patients. They stem from a need to identify better treatments. They are the most responsible, coordinated way to evaluate the safety, effectiveness, dose, and outcomes for new therapies. Many of today's standard cancer treatments were first proven to be effective in carefully planned clinical trials. Want to participate in a study? Search the open clinical trials at Wilmot Cancer Institute.